|
0
|
|
In vitro PK/PD modeling and simulation to accurately assess the antimicrobial activity of tigecycline against Mycobacterium abscessus.
(journals.asm.org)
|
Park H
…
Meibohm B
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#modeling
#infection
#amr
#pharmacodynamics
#susceptibility
|
|
0
|
|
Clinical Consequences of Delaying Implementation of Long-Acting Antiretroviral Therapy for People With HIV and Persistent Viremia in the United States.
(academic.oup.com)
|
Pei PP
…
Freedberg KA
Clinical Infectious Diseases
2026-02-04
|
#modeling
#viremia
#hiv
#adherence
|
|
0
|
|
A stochastic simulation-based approach to inform the relapsing mouse model study design for non-clinical assessment of tuberculosis.
(journals.asm.org)
|
Clary J
…
Berg A
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#modeling
#simulation
#drug development
#animal-models
#tb
|
|
0
|
|
Critical threshold target attainment rates for tazobactam combined with piperacillin among patients admitted to the ICU with hospital-acquired pneumonia.
(journals.asm.org)
|
Williamson R
…
Rhodes NJ
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#modeling
#infection
#amr
|
|
0
|
|
UniSyn: a multi-modal framework with knowledge transfer for anti-cancer drug synergy prediction.
(link.springer.com)
|
Chen Y
…
Luo X
Genome Biology
2026-02-04
|
#modeling
#cancer
#drug combination
#synergy
|
|
0
|
|
A modeling-based framework to evaluate forgiveness of tuberculosis treatment in a BALB/c relapsing mouse model.
(journals.asm.org)
|
Sordello S
…
Upton AM
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#modeling
#amr
#pharmacodynamics
#tb
|
|
0
|
|
Monthly dalbavancin dosing for suppressive therapy: a pharmacokinetic estimation analysis and case series.
(journals.asm.org)
|
Kufel WD
…
Volk C
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#modeling
#infection
#amr
|
|
0
|
|
A mechanism-based pharmacokinetic/pharmacodynamic analysis of polymyxin B-based combination therapy against carbapenem-resistant Klebsiella pneumoniae isolates with diverse phenotypic and genotypic resistance mechanisms.
(journals.asm.org)
|
Mahadevan R
…
Rao GG
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#modeling
#infection
#amr
#pharmacodynamics
|
|
0
|
|
In-kind Nutritional Supplementation for Persons With Drug-susceptible Tuberculosis and Their Household Contacts Would be Cost-effective for Reducing Tuberculosis Incidence and Mortality in Jharkhand, India: A Modeling Study.
(academic.oup.com)
|
Sinha P
…
Menzies NA
Clinical Infectious Diseases
2026-02-04
|
#modeling
#infection
#prevention
#nutrition
#tb
|
|
0
|
|
Pharmacokinetics and safety of fosfomycin and flomoxef administered as part of neonatal sepsis treatment (NeoSep1 Part 1).
(journals.asm.org)
|
Bekker A
…
Cressey TR
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#modeling
#amr
#sepsis
#neonatal
|
|
0
|
|
Effects of the COVID-19 Pandemic on Tuberculosis Outcomes in the United States: A Bayesian Analysis.
(academic.oup.com)
|
Swartwood NA
…
Menzies NA
Clinical Infectious Diseases
2026-02-04
|
#modeling
#infection
#transmission
#tb
|
|
0
|
|
Preclinical pharmacokinetics/pharmacodynamics studies defining the role of ethambutol in Mycobacterium kansasii lung disease.
(journals.asm.org)
|
Gumbo T
…
Srivastava S
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#modeling
#amr
#pharmacodynamics
#tb
|
|
0
|
|
Pharmacokinetic-pharmacodynamic target attainment with continuous infusion piperacillin in patients admitted to the ICU with hospital-acquired pneumonia.
(journals.asm.org)
|
Zurawska M
…
Rhodes NJ
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#modeling
#infection
#amr
#renal
|
|
0
|
|
A Point-of-Care Prediction Tool for Recurrent Tuberculosis.
(academic.oup.com)
|
Cox SR
…
Golub JE
Clinical Infectious Diseases
2026-02-04
|
#modeling
#screening
#prediction
#recurrence
#tb
|
|
0
|
|
The Impact of Influenza on US Working-Age Adults: Exploring the Benefits of the Recombinant Influenza Vaccine.
(academic.oup.com)
|
Torcel-Pagnon L
…
Chaves SS
Clinical Infectious Diseases
2026-02-04
|
#modeling
#vaccination
#influenza
#immunity
|
|
0
|
|
Population pharmacokinetics of caspofungin in critically ill Chinese children: a prospective observational study.
(journals.asm.org)
|
Xu N
…
Wang Y
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#modeling
#infection
#pediatric
|